glp 1 effects Peptide/GLP-1 Complications: 11 Hidden Risks and Side You Must Know Current Insights, Advantages and Challenges
Description
Disease C, Management R
Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme
& Coskun, T
A., Chawla P
In fact, one 2022 follow-up study showed that most weight lost on semaglutide was regained within a year of discontinuation
Diabetic gastropathy was described as a neuropathy occurring in the GI system of diabetic patients
